Gastrointestinal symptom control in palliative care (part 2);Gastroenterologische Symptomenkontrolle in der Palliativmedizin (Teil 2)

Gastroenterologe

Volumn 4, Issue 2, 2009, Pages 147-156

  Holtmann, M ^a   Siepmann, U ^b   Mahlkow, S ^b   Domagk, D ^c   Pott, G ^d  

^a St Vincenz Krankenhaus   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d Medizinische Klinik Gastroenterologie und Palliativmedizin   (Germany)

Author keywords

Gastrointestinal palliative care; Primary care; Symptom control; Terminal phase

Indexed keywords

EID: 68049137922     PISSN: 18619681     EISSN: 1861969X     Source Type: Journal    
DOI: 10.1007/s11377-008-0254-2     Document Type: Article

References (34)

1. Anthony Baron T, Mercadante S et al (2007) Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage 34: S49-S59
2. Aoun SM, Kristjanson U (2005) Challenging the framework for evidence in palliative care research. Palliat Med 19:461-465
3. Atkinson CV, Kirkham SR (1999) Unlicensed uses for medication in a palliative care unit. Palliat Med 13:145-152
4. Bausewein C, Fegg M, Radbruch L et al (2005) Validation and clinical application of the german version of the palliative care outcome scale. J Pain Symptom Manage 30:51-62
5. Becker G (2007) Medical and palliative management of malignant ascites. Cancer Treat Res 134: 459-467
6. Cardenas A, Gines P (2008) What's new in the treatment of ascites and spontaneous bacterial peritonitis. Curr Gastroenterol Rep 10:7-14
7. Doyle C, Crump M, Pintilie M et al (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266-1274
8. Droney J, Ross J, Gretton S et al (2008) Constipation in cancer patients on morphine. Support Care Cancer 16:453-459
9. Duerksen DR, Ting E,Thomson P et al (2004) Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition 20:760-763
10. Easson AM, Hinshaw DB, Johnson DL (2002) The role of tube feeding and total parenteral nutrition in advanced illness. J Am Coll Surg 194:225-228; discussion 228-229
11. Feuer DJ, Broadley KE (1999) Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Systematic Review Steering Committee. Ann Oncol 10: 1035-1041
12. Gines P, Cardenas A (2008)The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis 28:43-58
13. Helyer L, Easson AM (2008) Surgical approaches to malignant bowel obstruction. J Support Oncol 6: 105-113
14. Jones EA, Zylicz Z (2005) Treatment of pruritus caused by cholestasis with opioid antagonists. J Palliat Med 8:1290-1294
15. Kaasa S, Hjermstad MJ, Loge JH (2006) Methodological and structural challenges in palliative care research: how have we fared in the last decades? Palliât Med 20:727-734
16. Krouse RS, McCahill LE, Easson AM et al (2002) When the sun can set on an unoperated bowel obstruction: management of malignant bowel obstruction. J Am Coll Surg 195:117-128
17. Lianes LR, Fassbender K, Baracos VE et al (2006) Drug utilization review on a tertiary palliative care unit. J Pain Symptom Manage 31:457-464
18. McNicol E, Horowicz-Mehler N, Fisk RA et al (2003) Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 4:231-256
19. Meissner W, Schmidt U, Hartmann M et al (2000) Oral naloxone reverses opioid-associated constipation. Pain 84:105-109
20. Mercadante S, Casuccio A, Mangione S (2007) Medical treatment for Inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage 33:217-223
21. Mercadante S, Ripamonti C, Casuccio A et al (2000) Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 8:188-191
22. Mercadante S,Villari P, Fulfaro F (2001) Rifampicin in opioid-induced itching. Support Care Cancer 9: 467-468
23. Newshan G, Sherman DW (1999) Palliative care: pain and symptom management in persons with HIV/AIDS. Nurs Clin North Am 34:31-145
24. Philip J, Depczynski B (1997) The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy. J Pain Symptom Manage 13:104-111
25. Qulgley C (1996) 5HT3 receptor antagonists and pruritus due to cholestasis. Palliat Med 10:54
26. Ripamonti C, Mercadante S, Groff L et al (2000) Role of octreotide, scopolamine butylbromide, and hydration In symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 19:23-34
27. Rosenberg SM (2006) Palliation of malignant ascites. Gastroenterol Clin North Am 35:189-199
28. Sykes NP (2006) The pathogenesis of constipation. J Support Oncol 4:213-218
29. Tamsma J (2007) The pathogenesis of malignant ascites. CancerTreat Res 134:109-118
30. Thomas J, Karver S, Cooney GA et al (2008) Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358:2332-2343
31. Twycross R, Greaves MW, Handwerker H et al (2003) Itch scratching more than the surface. QJM 96:7-26
32. White C, Gilshenan K, Hardy J (2008) A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care. Support Care Cancer
33. Wirz S, Klaschik E (2005) Management of constipation in palliative care patients undergoing opioid therapy: is polyethylene glycol an option? Am J Hosp Palliat Care 22:375-381
34. Zylicz Z, Krajnik M, Sorge AA et al (2003) Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 26:1105-1112